Page 46 - Query Get News Today

Pediatric hospitalizations due to COVID-19 reached a peak in recent weeks, according to CDC data.

A recent study showed that increasing asset limits for low-income Medicare beneficiaries seeking Medicaid supplemental coverage would boost eligibility. It was the top story in rheumatology last week.

The No Surprises Act, which officially took effect Jan. 1 as a way to protect patients from unexpected medical bills, already faces several lawsuits from health care organizations.The bill was passed by Congress in 2020 as part of the coronavirus relief package. It was designed to safeguard patients against surprise out-of-network care costs.

Integrated data from the phase 2 ONSET-1 and phase 3 ONSET-2 clinical trials showed that OC-01 nasal spray effectively improves endogenous basal tear production in a heterogeneous dry eye disease population.The results of this analysis were presented in a poster session at the American Academy of Ophthalmology meeting by John Sheppard, MD.

Pediatric ophthalmologists reported more frequently performing immediate sequential bilateral cataract surgery in infants and children younger than 10 years, according to a presentation at the American Academy of Ophthalmology meeting.

Suicidal thoughts and behaviors in the U.S. adult population arise due to several factors, including geography, demographics, socioeconomic status and cultural setting, according to study findings published in MMWR.“Self-directed violence is a major public health issue in the United States. It includes a range of behaviors, from nonsuicidal intentional self-harm (ie, behavior in which the

The FDA granted orphan drug exclusivity for JZP258, an oral solution for the treatment of narcolepsy symptoms, according to the agent’s manufacturer. JZP258 (Jazz Pharmaceuticals plc), also known as Xywav, is a low-sodium oxybate aimed at correcting cataplexy and excessive daytime sleepiness in patients aged as young as 7 years, as well as narcolepsy in adults.

Early reduction in high-sensitivity C-reactive protein is “not a good biomarker” for canakinumab’s protective impact on future gout flares, according to data published in Arthritis Care & Research.However, results from a prevalent gout subgroup suggest there may be a potential role for using reduced early high-sensitivity CRP as a biomarker for interleukin-1 inhibition

Healio Psoriatic Disease | Drug adherence is one of the biggest barriers to topical psoriasis treatment. Messy vehicles, multiple daily applications and cost factors can all impact a patient’s adherence rates. Mathias Tiedemann Svendsen, MD, PhD, specialist in dermato-venereology and clinical assistant for the department of dermatology and allergy center at Odense University Hospital in Denmark, regularly conducts

Nearly 80% of U.S. adults with obesity and diabetes have hepatic steatosis and an increased risk for advanced fibrosis, according to study findings published in Obesity. “In people with diabetes, even those in the early stages of obesity, the majority had steatosis, and the prevalence of fibrosis was high,” Kenneth Cusi, MD, FACP, FACE, chief of the division of endocrinology,